Jonathan Heller
Geen lopende functies
Profiel
Jonathan Heller was the founder of Teton Therapeutics, Inc. which was founded in 2017, where he held the title of Chief Executive Officer from 2017 to 2019.
He also held the position of Director-Early Stage Programs at BioMarin Pharmaceutical, Inc. from 2013 to 2015.
Additionally, he held the title of Vice President-Research Operations at Erimos Pharmaceuticals LLC and Chief Science Officer, Head-Research & Development at Ocean Biomedical, Inc. (United States).
Dr. Heller received his undergraduate degree from The Reed Institute, his MBA from the University of California, Berkeley, and his doctorate from John Hopkins University Atlantic Basin Policy Institute.
Eerdere bekende functies van Jonathan Heller
| Bedrijven | Functie | Einde |
|---|---|---|
Teton Therapeutics, Inc.
 Teton Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Teton Therapeutics, Inc. develops novel therapies for neurofibromatosis. The private company is based in Belmont, MA. The company was founded by Jonathan Heller. | Algemeen Directeur | 01-01-2019 |
| BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | 01-01-2015 |
Erimos Pharmaceuticals LLC
 Erimos Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Erimos Pharmaceuticals LLC manufactures drugs. It is a biopharmaceutical company focused primarily on the discovery, development and commercialization of small molecule drugs to prevent and treat cancer. The firm’s pre-clinical programs are underway to create advancements in treating other serious medical conditions including influenza, Alzheimer’s disease, diabetes, psoriasis, obesity, and infectious disease. The company was founded by Franklin C. Jesse Jr. and Jeffrey Khoo in 2000 and is headquartered in Houston, TX. | Corporate Officer/Principal | - |
Ocean Biomedical, Inc. (United States)
 Ocean Biomedical, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Ocean Biomedical, Inc. is a biopharmaceutical company. It engages in the business of discovering and developing therapeutic products in oncology, fibrosis, infectious diseases and inflammation. The company was founded by Chirinjeev Kathuria, Jonathan Kurtis and Jack A. Elias on January 2, 20219 and is headquartered in Providence, RI. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Jonathan Heller
| The Reed Institute | Undergraduate Degree |
| University of California, Berkeley | Masters Business Admin |
| John Hopkins University Atlantic Basin Policy Institute | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Erimos Pharmaceuticals LLC
Erimos Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Erimos Pharmaceuticals LLC manufactures drugs. It is a biopharmaceutical company focused primarily on the discovery, development and commercialization of small molecule drugs to prevent and treat cancer. The firm’s pre-clinical programs are underway to create advancements in treating other serious medical conditions including influenza, Alzheimer’s disease, diabetes, psoriasis, obesity, and infectious disease. The company was founded by Franklin C. Jesse Jr. and Jeffrey Khoo in 2000 and is headquartered in Houston, TX. | Health Technology |
Teton Therapeutics, Inc.
Teton Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Teton Therapeutics, Inc. develops novel therapies for neurofibromatosis. The private company is based in Belmont, MA. The company was founded by Jonathan Heller. | Health Technology |
Ocean Biomedical, Inc. (United States)
Ocean Biomedical, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Ocean Biomedical, Inc. is a biopharmaceutical company. It engages in the business of discovering and developing therapeutic products in oncology, fibrosis, infectious diseases and inflammation. The company was founded by Chirinjeev Kathuria, Jonathan Kurtis and Jack A. Elias on January 2, 20219 and is headquartered in Providence, RI. | Commercial Services |
